Novanta Other Liab from 2010 to 2024

NOVT Stock  USD 173.43  3.64  2.14%   
Novanta Other Liabilities yearly trend continues to be comparatively stable with very little volatility. Other Liabilities is likely to outpace its year average in 2024. From the period from 2010 to 2024, Novanta Other Liabilities quarterly data regression had r-value of  0.68 and coefficient of variation of  58.68. View All Fundamentals
 
Other Liabilities  
First Reported
2000-03-31
Previous Quarter
23 M
Current Value
22.1 M
Quarterly Volatility
41.2 M
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Novanta financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Novanta's main balance sheet or income statement drivers, such as Depreciation And Amortization of 23.7 M, Interest Expense of 27.1 M or Total Revenue of 925.7 M, as well as many indicators such as Price To Sales Ratio of 7.19, Dividend Yield of 0.0 or PTB Ratio of 9.41. Novanta financial statements analysis is a perfect complement when working with Novanta Valuation or Volatility modules.
  
Check out the analysis of Novanta Correlation against competitors.
For more information on how to buy Novanta Stock please use our How to Invest in Novanta guide.

Latest Novanta's Other Liab Growth Pattern

Below is the plot of the Other Liab of Novanta over the last few years. It is Novanta's Other Liabilities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Novanta's overall financial position and show how it may be relating to other accounts over time.
Other Liab10 Years Trend
Slightly volatile
   Other Liab   
       Timeline  

Novanta Other Liab Regression Statistics

Arithmetic Mean26,366,568
Geometric Mean20,890,856
Coefficient Of Variation58.68
Mean Deviation13,118,606
Median22,982,000
Standard Deviation15,472,833
Sample Variance239.4T
Range51.3M
R-Value0.68
Mean Square Error137.6T
R-Squared0.47
Significance0.01
Slope2,362,330
Total Sum of Squares3351.7T

Novanta Other Liab History

202433.4 M
202326.4 M
202223 M
202147.6 M
202040.5 M
201953.4 M
201837 M

About Novanta Financial Statements

Novanta shareholders use historical fundamental indicators, such as Other Liab, to determine how well the company is positioned to perform in the future. Although Novanta investors may analyze each financial statement separately, they are all interrelated. The changes in Novanta's assets and liabilities, for example, are also reflected in the revenues and expenses on on Novanta's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Other Liabilities26.4 M33.4 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Novanta Stock Analysis

When running Novanta's price analysis, check to measure Novanta's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novanta is operating at the current time. Most of Novanta's value examination focuses on studying past and present price action to predict the probability of Novanta's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novanta's price. Additionally, you may evaluate how the addition of Novanta to your portfolios can decrease your overall portfolio volatility.